VANGUARD GROUP INC - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 34 filers reported holding NRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$377,154
-47.2%
1,450,593
-1.9%
0.00%
Q2 2023$714,687
-26.6%
1,478,1530.0%0.00%
Q1 2023$974,250
-39.2%
1,478,153
+2.4%
0.00%
Q4 2022$1,601,911
+50.4%
1,443,163
+0.2%
0.00%
Q3 2022$1,065,000
+62.1%
1,440,265
+31.6%
0.00%
Q2 2022$657,000
-75.1%
1,094,713
+1.8%
0.00%
Q1 2022$2,634,000
-53.0%
1,075,317
-8.3%
0.00%
Q4 2021$5,603,000
-39.6%
1,172,233
+17.2%
0.00%
Q3 2021$9,271,000
+25.2%
1,000,123
+56.9%
0.00%
Q2 2021$7,407,000637,4160.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders